http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-116-Y

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_455f29df16ac2dc58f5d26192b55d03c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
filingDate 2009-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0fa2d7a71f9391807e541ebd615d10a
publicationDate 2009-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MD-116-Y
titleOfInvention Method of restoring lymphocirculation through the thoracic duct in liver cirrhosis with refractory ascites
abstract The invention relates to medicine, especially to hepatology and can be used to restore lymphocirculation through the thoracic duct in patients with liver cirrhosis with refractory ascites. The essence of the invention is that under local anesthesia a horizontal incision of 4 ... 5 cm is made in the left supraclavicular region, the cervical fascia is divided I ... IV, the internal jugular vein is mobilized and the left venous angle is separated, the thoracic lymphatic duct is separated in the angle region left venous, the thoracic lymphatic duct is mobilized throughout the cervical segment with release from the adherents, the related lymphatic branches are mobilized, one of the branches is prepared, which has a larger diameter, through which a buttoned probe with the diameter of 1 ... 3 is introduced. mm in the lumen of the thoracic lymphatic duct, then temporarily tightens with the help of a clamp the terminal portion of the thoracic lymphatic duct and with the help of a syringe, an anesthetic solution is introduced under retrograde pressure with filling of the lumen of the cervical portion of the duct, the other related lymphatic branches are divided and ligature, and after the restoration of the lymphocirculation, the terminal portion of the duct is released thoracic lymph. The wound is sutured on the layers. As an anesthetic solution, 2 or 10% lidocaine solution in the amount of 5 ... 10 ml is used.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-1154-Z
priorityDate 2009-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252

Total number of triples: 13.